Ind-Swift Laboratories is set to transform its Samba, Jammu & Kashmir, manufacturing facility with a Rs. 40 crore upgrade aimed at meeting EU-GMP and PIC/S standards. The move positions the firm to significantly expand its global exports.

The enhancements will improve environmental sustainability, strengthen material governance, and boost utility reliability. The company expects the upgrade to be completed within 8-12 months, with EU-GMP approval anticipated within 8-9 months. Once certified, Ind-Swift plans to file approximately 15-20 molecules across Europe, the UK, Australia, Canada, and South Africa.

Currently, the Samba unit produces ointments for the domestic market, including its own brands and contract manufacturing, along with tablets, capsules, and dry syrups. The facility generates annual sales of ₹360 million, with a 10% profit margin.

With the upgrade, Ind-Swift aims to push revenues to Rs. 75-80 crore and lift its profit margin to 18-20% from FY27-28 onwards. The modernization will enhance process robustness, reduce manual intervention, reinforce data integrity, and ensure consistent high-quality output.

“These initiatives are designed to future-proof the facility, enable scalable growth, elevate global compliance readiness, and reinforce patient safety and long-term business sustainability,” the company said in a statement.

Confirming the plans, Sahil Munjal, Managing Director (Exports), said: "We are witnessing increased demand for our products in the export markets. The upgradation of the Jammu facility will enable us to expand our product portfolio in Europe, UK, Australia and other markets, significantly strengthening our global footprint.”

The Samba facility upgrade marks a key milestone in Ind-Swift’s transformation strategy, highlighting its focus on regulatory excellence, export-led growth, and sustainable value creation.

In Q3 FY26, the company's operating EBITDA rose 6.60% quarter-on-quarter to Rs. 9.11 crore. Profit After Tax surged 22.67% to Rs. 10.74 crore. Total Revenue increased 5.21% to Rs. 177.06 crore.